Enhancing Incentives to Improve Corporate Value over the Medium to Long Term through the Issuance of Stock Acquisition Rights
First written in FY2021-Q1. 4 of 9 entries say "Achieved", first in FY2021-Q1. Latest entry: 2026-05-28.
- 2026-05-28SoftenedShare Issuance and Disposal
「Total remaining stock acquisition rights 875 150 / Number of stock acquisition rights to be cancelled 8 50 / Remaining stock acquisition rights after cancellation 867 100」
A portion of the fourth- and sixth-series stock acquisition rights was cancelled. The number of outstanding stock options declined, but the overall program has not ended. - FY2026-H1AchievedAnnual report
「Ninth Series of Stock Acquisition Rights Resolution date 26 November 2025 Categories and number of eligible recipients (people) Directors of subsidiaries 6 Employees of subsidiaries 2 Number of stock acquisition rights (units) 140 Number of shares underlying the stock acquisition rights (shares) 14,000」
The Ninth Series of Stock Acquisition Rights, comprising 140 rights representing 14,000 shares, was issued on 25 December 2025 to 6 Directors and 2 employees of subsidiaries. - FY2025-H1AdvancedAnnual report
「Eighth Series of Stock Acquisition Rights Number of stock acquisition rights (units) ※ 150 Number of shares underlying the stock acquisition rights (shares) ※ 15,000 Exercise period for the stock acquisition rights ※ From 23 November 2026 To 21 November 2034」
The Eighth Series of Stock Acquisition Rights, comprising 150 rights representing 15,000 shares, was issued to Directors and employees of subsidiaries on 20 December 2024. - FY2024-Q1AchievedAnnual report
「At a meeting of the Board of Directors held on 27 November 2023, we resolved to issue stock acquisition rights (the "Stock Acquisition Rights") to our employees and to the Directors and employees of our subsidiaries, and issued them on 26 December 2023.」
The Seventh Series of Stock Acquisition Rights representing 29,000 common shares was issued for employees and officers and employees of subsidiaries on 26 December 2023. - FY2023-Q1AchievedAnnual report
「At a meeting of the Board of Directors held on 25 November 2022, we resolved to issue stock acquisition rights to our employees and to the Directors and employees of our subsidiaries, and issued them on 23 December 2022.」
The Sixth Series of Stock Acquisition Rights representing 53,000 shares was issued on 23 December 2022. - FY2022AdvancedAnnual report
「The total number of shares deliverable upon exercise of these stock acquisition rights is 53,000 common shares of the Company. If the number of shares granted in respect of these stock acquisition rights is adjusted under 3.(1) below, the total will be the adjusted number of shares granted multiplied by the number of these stock acquisition rights.」
After the filing date, the issuance of stock acquisition rights representing 53,000 shares was approved for employees and officers and employees of subsidiaries, with the aim of increasing motivation to enhance corporate value over the medium to long term. - FY2022-Q2AdvancedAnnual report
「Fifth Series of Stock Acquisition Rights Resolution date 25 November 2021 Number of stock acquisition rights (units) ※ 795 Number of shares underlying the stock acquisition rights (shares) ※ 79,500」
For the Fifth Series of Stock Acquisition Rights approved on 25 November 2021, the filing specified 795 rights, 79,500 underlying shares, an exercise price of ¥3,148, and an exercise period from 26 November 2023 to 24 November 2031. - FY2021AdvancedAnnual report
「At a meeting of the Board of Directors held on 25 November 2021, we resolved to issue stock acquisition rights as described below to our employees, the Directors and employees of our subsidiaries, and the Directors of our affiliates.」
At a Board of Directors meeting held after the filing date, the issuance of 935 stock acquisition rights representing 93,500 shares was approved for employees, officers and employees of subsidiaries, and Directors of affiliates. - FY2021-Q1AchievedAnnual report
「At a meeting of the Board of Directors held on 20 November 2020, we resolved to issue stock acquisition rights to our Directors and employees and to the Directors and employees of our subsidiaries, and issued them on 23 December 2020.」
To align interests with shareholders and increase motivation to enhance corporate value over the medium to long term, 1,706 stock acquisition rights representing 170,600 common shares were issued to Directors, employees and others. The exercise period runs from 21 November 2022 to 19 November 2030.